[Current insulin therapy--avoidable errors].
Since its introduction in 1922, insulin therapy has undergone constant development and improvement. Today, the spectrum ranges from short- to very long-acting depot insulins, and "human" insulins. Further stages in the development of this form of treatment have been intensive insulin therapy, self-measurement of blood sugar, development of insulin-analogues and the use of insulin pumps or pens, to mention but a few. As a reflection of how widespread insulin therapy in the doctor's office has become and what the frontiers are, the present paper lists a range of 15 errors, and discusses how they can be avoided and insulin treatment thus further optimized.
Mehnert
H
H
Forschergruppe Diabetes e.V., Institut für Diabetesforschung am Krankenhaus Schwabing, München.
D000284:Administration, Oral; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D008508:Medication Errors; D010353:Patient Education as Topic
D007004:Hypoglycemic Agents; D007328:Insulin
Aktuelle Insulintherapie--vermeidbare Fehler.